MedTrace Logo

Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies

NCT06978595 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8171

Last updated 2025-05-18

No results posted yet for this study

Summary

This original research investigates the critical issue of gastrointestinal (GI) second primary malignancies (SPMs) in patients with signet ring cell carcinoma (SRCC), a rare and aggressive subtype of colorectal cancer. Utilizing the Surveillance, Epidemiology, and End Results (SEER) database, the investigators assessed the risk of GI SPMs, particularly within 2-11 months post-SRCC diagnosis.

Conditions

  • Colorectal Carcinoma
  • Cancer
  • Signet Ring Adenocarcinoma of the Colon

Sponsors & Collaborators

  • asmaa salama ibrahim

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-01
Primary Completion
2021-12-30
Completion
2021-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06978595 on ClinicalTrials.gov